Trial Profile
A retrospective study of raltegravir in HIV-1 patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Sep 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 09 Sep 2015 New trial record
- 26 Aug 2015 Results published in the Journal of Antimicrobial Chemotherapy.